# Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

> **NCT00010023** · PHASE1 · COMPLETED · sponsor: **NYU Langone Health**

## Conditions studied

- Cancer

## Interventions

- **DRUG:** capecitabine
- **DRUG:** cisplatin

## Key facts

- **NCT ID:** NCT00010023
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-08
- **Primary completion:** 2007-08
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2011-04-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00010023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00010023, "Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00010023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*